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Special notes
While a company's brand name, or a registered trade mark, respectively, are not necessarily given in the present paper, it must not be presumed that such name or mark was free.
As medical science is a rapidly developing field, informations and recommendations given in these guidelines do represent the state-of-the-art knowledge as it stands at the time of submission of the paper. Utmost care has been taken by the expert panel to extract that knowledge from the scientific literature as well as their personal experience. Having said that, the user remains fully liable for all applications based upon recommendations given in the present paper.
The reader's attention is drawn to the fact that oral contraceptives (OCs) and intrauterine levonorgestrel-releasing systems are not specifically approved in b) The cardinal symptom is chronic pelvic pain. Infertility is common.
There are about 20.000 hospital admissions per year for endometriosis in Germany . Pathologically and histologically, endometriosis is a benign disease. However, infiltrative growth into adjacent organs is possible requiring extensive surgical procedures.
Etiology, pathology, and staging
Statement:
Etiology and pathogenesis of endometriosis are not fully understood. Therefore, a causal therapy is not known to date.
Recommendation:
All staging systems known to date have their limitations. In order to ensure the international comparability of data, the use of the rASRM staging system -and in cases of deep infiltrating endometriosis the additional use of the ENZIAN classification -is recommended.
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In general, the diagnosis of endometriosis is to be established histologically. Hence, diagnostic laparoscopy is essential for the diagnostic work-up (Walter et al. 2001 ). 
General comments
Peritoneal endometriosis
Statements:
a) The diagnosis of peritoneal endometriosis is made laparoscopically. 
Ovarian endometriosis (endometriomas)
Statement:
The diagnosis of ovarian endometriomas is primarily made by transvaginal ultrasound.
Recommendations: a) For primary treatment of ovarian endometriomas, the cyst wall should be removed surgically. Fenestration alone is considered insufficient. b) Endocrine drug treatment alone is neither effective in eliminating an ovarian endometrioma (and, consequently, to replace its surgical removal) -nor in compensating for incomplete surgical removal. Therefore, it is not recommended.
Differential diagnosis
In ovarian endometriomas, often a typical echogenic pattern is found (Hudelist et al. 2009b ). However, there are also sonographically complex ovarian masses with heterogeneous appearance making it sometimes difficult to differentiate between functional ovarian cysts on the one side and dermoid cysts, kystomas, or ovarian malignant neoplasms on the other side. If a laparoscopic approach is scheduled in unclear ovarian findings, the DGGG S1 Guidelines for Laparoscopic Surgery of 
Deep infiltrating endometriosis
Statements: a) Deep infiltrating endometriosis (DIE) is defined as involvement of the rectovaginal septum, vaginal fornix, retroperitoneum (pelvic side wall, parametrium), bowel, ureters, and urinary bladder.
b) The primary diagnosis of DIE is made clinically with rectovaginal palpation, inspection with divided specula, vaginal ultrasound, and transabdominal ultrasound of the kidneys being mandatory.
Recommendations: a) For treatment, complete resection of DIE should be performed. Nonetheless, compromises must be made as preservation of fertility often is imperative.
Considering that the disease is benign and potentially relevant complications may occur, the extent of resection should be thoroughly discussed and agreed upon with the patient.
b) Treatment of DIE should be carried out in specialized centers with a multidisciplinary approach ).
c) If patients with DIE are to be managed conservatively -as well as pre-and postoperatively -sonographic examination of the kidneys is mandatory in order to avoid overlooking silent hydronephrosis. DIE-associated hydronephrosis is an absolute indication of appropriate diagnosis and treatment.
Hormone replacement therapy in patients with endometriosis
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Premenopausal patients who have undergone hysterectomy because of endometriosis -proper indication provided -should receive a combined estrogenprogestin HRT. In postmenopause, in view of the fact that there is a potential risk of malignancy (see paragraph on endometriosis-associated malignancy), combined estrogen-progestin HRT -or tibolone -is recommended as well (Moen et al. 2010, Soliman and Hillard 2006) . Nonetheless, the problem of breast cancer risk has to be balanced against that -and an individual decision made together with the patient (see also S3 Guidelines for HRT in the peri-and postmenopause, AWMF Registry
No. 015-062).
Adenomyosis
The diagnosis of adenomyosis is primarily established clinically by vaginal ultrasonography and/or MRI. Most often, it is only the histological result after hysterectomy that is proving. 
Endometriosis and infertility
Statements: a) While a causal relationship has not been resolved yet, endometriosis and infertility are often associated.
b) For the treatment of women with both endometriosis and infertility, appropriate skills and experience in infertility surgery, as well as cooperation with centers for reproductive medicine are required.
Recommendations:
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aktueller Stand: 08/2013 a) In women with both infertility and endometriosis, the implants should be surgically removed for the improvement of fertility.
b) In cases of recurrence, assisted reproductive technologies are superior to repeated surgery in terms of pregnancy rate. In repeat operations for ovarian endometriosis, the surgery-related reduction of ovarian reserve is to be considered.
c) Postoperative treatment with GnRH analogs was ineffective in improving spontaneous pregnancy rates and is, therefore, not recommended.
d) Any drug treatment for endmetriosis alone does not improve fertility and should not be applied from a reproductive-medicine perspective.
Psychosomatic aspects
Recommendation:
Psychosomatic aspects in the treatment of patients with endometriosis should be considered and integrated early on.
Complementary and integrative treatment approaches
No statements, no recommendations. After extensive surgery -especially for deep infiltrating endometriosis, after repeat endometriosis operations, or in patients with chronic pain, there often is a need for rehabilitation.
This need mentioned should be assessed, and measures of rehabilitation, or aftercare, respectively, be initiated. 
